CIK 0001958777 · <br>Emerging growth company
FibroBiologics, Inc.
Sign in to watch- Ticker
- FBLG
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 863329066
- Phone
- 281-671-5150
- Business address
- 9350 KIRBY DRIVE, SUITE 300, HOUSTON, TX, 77054
- Former names
- FibroBiologics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-12 | Coen Stacy Ann Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-12 | Cilento Richard C. Jr. Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-06-09 | Davis Jason Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +450,000 | 450,000 | ||
| 2025-05-27 | Khoja Hamid Chief Scientific Officer | Purchase | +20,000 | $0.84 | $17K | 31,250 |
| 2025-03-26 | O'HEERON PETE CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +453,000 | 453,000 | ||
| 2025-03-26 | GARCIA RUBEN A General Counsel | Grant or award · Stock Option (Right to Buy) | +189,000 | 189,000 | ||
| 2025-03-26 | Khoja Hamid CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +189,000 | 189,000 | ||
| 2024-12-27 | O'HEERON PETE Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +406,339 | 406,339 | ||
| 2024-12-27 | Khoja Hamid CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option (Right to Buy) | +176,200 | 176,200 | ||
| 2024-12-27 | GARCIA RUBEN A General Counsel | Grant or award · Stock Option (Right to Buy) | +176,200 | 176,200 | ||
| 2024-12-09 | O'HEERON PETE Chief Executive Officer | Gift | −100,000 | 5,906,647 | ||
| 2024-12-03 | O'HEERON PETE Chief Executive Officer | Gift | −50,000 | 6,006,647 | ||
| 2024-08-27 | Niklas Victoria Ninon Olivia Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-08-27 | Link Matthew Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-08-27 | Hoffman Robert E. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-08-27 | Coen Stacy Ann Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-08-27 | Cilento Richard C. Jr. Director | Grant or award · Stock Option (Right to Buy) | +5,000 | 5,000 | ||
| 2024-08-12 | O'HEERON PETE Chief Executive Officer | Purchase | +8,500 | $1.91 | $16K | 6,056,647 |
| 2024-08-12 | Khoja Hamid Chief Scientific Officer | Purchase | +10,000 | $1.90 | $19K | 11,250 |
| 2024-03-01 | GARCIA RUBEN A General Counsel | Grant or award · Stock Option (Right to Buy) | +180,000 | 180,000 |
Page 2 of 2 · 40 trades